PMD
Income statement / Annual
Last year (2024), Psychemedics Corporation's total revenue was $19.69 M,
a decrease of 10.92% from the previous year.
In 2024, Psychemedics Corporation's net income was -$1.86 M.
See Psychemedics Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$19.69 M |
$22.10 M |
$25.24 M |
$24.91 M |
$21.36 M |
$37.68 M |
$42.67 M |
$39.70 M |
$38.98 M |
$26.98 M |
| Cost of Revenue |
$12.58 M
|
$13.69 M
|
$15.95 M
|
$14.65 M
|
$16.47 M
|
$21.23 M
|
$22.06 M
|
$19.88 M
|
$17.53 M
|
$14.26 M
|
| Gross Profit |
$7.10 M
|
$8.41 M
|
$9.29 M
|
$10.26 M
|
$4.89 M
|
$16.44 M
|
$20.62 M
|
$19.82 M
|
$21.45 M
|
$12.72 M
|
| Gross Profit Ratio |
0.36
|
0.38
|
0.37
|
0.41
|
0.23
|
0.44
|
0.48
|
0.5
|
0.55
|
0.47
|
| Research and Development Expenses |
$749,000.00
|
$1.14 M
|
$1.33 M
|
$1.13 M
|
$1.28 M
|
$1.57 M
|
$1.55 M
|
$1.36 M
|
$1.42 M
|
$1.63 M
|
| General & Administrative Expenses |
$5.70 M
|
$7.19 M
|
$5.86 M
|
$6.13 M
|
$6.10 M
|
$7.22 M
|
$6.43 M
|
$5.64 M
|
$4.97 M
|
$4.56 M
|
| Selling & Marketing Expenses |
$2.55 M
|
$3.00 M
|
$3.19 M
|
$2.80 M
|
$3.58 M
|
$4.66 M
|
$5.03 M
|
$4.67 M
|
$4.96 M
|
$5.05 M
|
| Selling, General & Administrative Expenses |
$8.25 M
|
$10.19 M
|
$9.05 M
|
$8.93 M
|
$9.67 M
|
$11.88 M
|
$11.46 M
|
$10.31 M
|
$9.93 M
|
$9.61 M
|
| Other Expenses |
$0.00
|
$0.00
|
$43,000.00
|
-$1.03 M
|
-$140,000.00
|
$58,000.00
|
$43,000.00
|
$20,000.00
|
-$134,000.00
|
-$124,588.00
|
| Operating Expenses |
$8.99 M
|
$11.33 M
|
$10.37 M
|
$10.06 M
|
$10.95 M
|
$13.45 M
|
$13.01 M
|
$11.67 M
|
$11.34 M
|
$11.25 M
|
| Cost And Expenses |
$21.58 M
|
$25.02 M
|
$26.32 M
|
$24.70 M
|
$27.43 M
|
$34.68 M
|
$35.06 M
|
$31.54 M
|
$28.87 M
|
$25.50 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$49,000.00
|
$75,000.00
|
$134,000.00
|
$149,000.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$26,000.00
|
$17,000.00
|
$0.00
|
$49,000.00
|
$75,000.00
|
$59,000.00
|
$106,000.00
|
$0.00
|
$134,000.00
|
$124,588.00
|
| Depreciation & Amortization |
$2.08 M
|
$2.67 M
|
$3.32 M
|
$3.69 M
|
$3.63 M
|
$2.91 M
|
$3.06 M
|
$2.81 M
|
$2.29 M
|
$1.73 M
|
| EBITDA |
$191,000.00 |
-$251,000.00 |
$2.23 M |
$3.90 M |
-$2.44 M |
$5.91 M |
$7.61 M |
$10.96 M |
$12.40 M |
$2.75 M |
| EBITDA Ratio |
0.01
|
-0.01
|
0.09
|
0.16
|
-0.11
|
0.16
|
0.18
|
0.28
|
0.32
|
0.1
|
| Operating Income Ratio |
-0.1
|
-0.13
|
-0.04
|
-0.14
|
-0.28
|
0
|
0.18
|
0.21
|
0.26
|
0.05
|
| Total Other Income/Expenses Net |
-$23,000.00
|
-$517,000.00
|
$43,000.00
|
-$1.03 M
|
-$140,000.00
|
$58,000.00
|
$43,000.00
|
$20,000.00
|
-$134,000.00
|
-$124,000.00
|
| Income Before Tax |
-$1.92 M
|
-$3.44 M
|
-$1.04 M
|
-$821,000.00
|
-$6.21 M
|
$3.06 M
|
$7.65 M
|
$8.18 M
|
$9.98 M
|
$1.35 M
|
| Income Before Tax Ratio |
-0.1
|
-0.16
|
-0.04
|
-0.03
|
-0.29
|
0.08
|
0.18
|
0.21
|
0.26
|
0.05
|
| Income Tax Expense |
-$55,000.00
|
$716,000.00
|
$44,000.00
|
-$156,000.00
|
-$2.35 M
|
$1.51 M
|
$3.07 M
|
$2.06 M
|
$3.30 M
|
-$164,388.00
|
| Net Income |
-$1.86 M
|
-$4.15 M
|
-$1.08 M
|
-$665,000.00
|
-$3.86 M
|
$1.54 M
|
$4.58 M
|
$6.12 M
|
$6.68 M
|
$1.51 M
|
| Net Income Ratio |
-0.09
|
-0.19
|
-0.04
|
-0.03
|
-0.18
|
0.04
|
0.11
|
0.15
|
0.17
|
0.06
|
| EPS |
-0.32 |
-0.72 |
-0.19 |
-0.12 |
-0.7 |
0.28 |
0.83 |
1.11 |
1.23 |
0.28 |
| EPS Diluted |
-0.32 |
-0.72 |
-0.19 |
-0.12 |
-0.7 |
0.28 |
0.83 |
1.1 |
1.22 |
0.28 |
| Weighted Average Shares Out |
$5.87 M
|
$5.74 M
|
$5.63 M
|
$5.55 M
|
$5.52 M
|
$5.51 M
|
$5.51 M
|
$5.49 M
|
$5.45 M
|
$5.41 M
|
| Weighted Average Shares Out Diluted |
$5.87 M
|
$5.74 M
|
$5.63 M
|
$5.55 M
|
$5.52 M
|
$5.53 M
|
$5.52 M
|
$5.56 M
|
$5.48 M
|
$5.41 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
